Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRAL | Common Stock | Purchase | $103K | +7.63K | +0.22% | $13.52 | 3.5M | Oct 1, 2024 | See Footnotes | F1, F2, F3 |
transaction | GRAL | Common Stock | Purchase | $267K | +20K | +0.57% | $13.37 | 3.52M | Oct 2, 2024 | See Footnotes | F1, F2, F4 |
transaction | GRAL | Common Stock | Purchase | $445K | +35K | +0.99% | $12.71 | 3.56M | Oct 3, 2024 | See Footnotes | F1, F2, F5 |
transaction | GRAL | Common Stock | Other | $880K | +70K | +1.97% | $12.57 | 3.63M | Oct 3, 2024 | See Footnotes | F1, F2, F6, F7 |
transaction | GRAL | Common Stock | Purchase | $209K | +16.2K | +0.45% | $12.92 | 3.64M | Oct 9, 2024 | See Footnotes | F1, F2, F8 |
Id | Content |
---|---|
F1 | Securities are owned directly by funds (the "CRCM Funds") and separately managed accounts managed by CRCM LP, a Delaware limited partnership and a registered investment adviser with the U.S. Securities and Exchange Commission (the "Investment Manager"). The Reporting Person holds ownership interests in the CRCM Funds. The Reporting Person is the managing partner of the Investment Manager and may be deemed to have an indirect pecuniary interest in a percentage of the securities held by the CRCM Funds. The CRCM Funds and separately managed accounts hold directly in the aggregate 3,644,855 shares of common stock of the Issuer ("common stock"). The Reporting Person may be deemed to beneficially own a percentage of shares of common stock by virtue of his proportional interest in the CRCM Funds. |
F2 | The Reporting Person disclaims any beneficial ownership of any of the Issuer's securities reported herein, or otherwise, except as to securities representing the Reporting Person's proportional interest in the CRCM Funds, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such other securities of the Issuer for purposes of Section 16 or for any other purpose. |
F3 | On October 1, 2024, the CRCM Funds acquired 7,629 shares of common stock in a series of transactions at prices ranging from $13.25 to $13.81 per share. The price reported in Column 4 is a weighted average price. The detailed breakdown of executed transactions will be furnished upon request. |
F4 | On October 2, 2024, the CRCM Funds acquired 20,000 shares of common stock in a series of transactions at prices ranging from $13.10 to $13.54 per share. The price reported in Column 4 is a weighted average price. The detailed breakdown of executed transactions will be furnished upon request. |
F5 | On October 3, 2024, the CRCM Funds acquired 35,000 shares of common stock in a series of transactions at prices ranging from $12.57 to $13.03 per share. The price reported in Column 4 is a weighted average price. The detailed breakdown of executed transactions will be furnished upon request. |
F6 | The shares of the common stock were contributed by a limited partner of a CRCM Fund to the CRCM Funds as an in-kind subscription for ownership interests in such fund. |
F7 | Represents the closing price per share of the common stock on the date on which the shares were contributed. |
F8 | On October 9, 2024, the CRCM Funds acquired 16,200 shares of common stock in a series of transactions at prices ranging from $12.73 to $13.14 per share. The price reported in Column 4 is a weighted average price. The detailed breakdown of executed transactions will be furnished upon request. |